View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Novo Nordisk Pharmatech to Attend The Bioprocessing Summit, US

The 2017 Bioprocessing Summit in Boston, MA, convenes more than 1,000 international bioprocess professionals to share practical solutions for today’s bioprocess challenges.

Taking place from 13 August to 16 August at the Sheraton Boston. the Congress is a commercially focused event bringing together the full value chain and looks at commercialising and pushing forward the adoption of biosimilars globally.

Novo Nordisk Pharmatech invites you to come visit its booth (booth #108) to discover more about recombinant insulin for innovative biologics and pharmaceutical-grade quaternary ammonium compounds.

Novo Nordisk Pharmatech remains one of the leading worldwide suppliers of recombinant insulin. Its recombinant insulin is a key component in serum-free growth media for mammalian cells and approved by regulatory bodies worldwide, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Its products are manufactured to current good manufacturing practice (cGMP) standards and it guarantees:

  • Global regulatory compliance
  • Consistent high quality
  • Extensive regulatory documentation
  • Continuous availability
  • Secure global supply chain
  • High levels of service and support

The company delivers a proven record of product purity, reliability and consistency, and is able to tailor high-quality products for future therapies.

Chinese hamster ovary (CHO) cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum containing to Serum free and further on to chemically defined media.

UAB in collaboration with Novo Nordisk Pharmatech has shown that addition of animal origin-free insulin to three leading commercially available off-the-shelf chemically defined media resulted in significant increases in viable cell density.

In addition, insulin has been proven to aid in the expression of difficult-to-express proteins.

Stop by Novo Nordisk Pharmatech’s booth for a talk about how insulin could play an important role in your upstream process and for the chance to win an Amazon Kindle.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology